Susan E Graf - Net Worth and Insider Trading

Susan E Graf Net Worth

The estimated net worth of Susan E Graf is at least $2,004 dollars as of 2024-11-29. Susan E Graf is the Director of Finch Therapeutics Group Inc and owns about 167 shares of Finch Therapeutics Group Inc (FNCH) stock worth over $2,004. Details can be seen in Susan E Graf's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Susan E Graf has not made any transactions after 2023-06-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Susan E Graf

To

Susan E Graf Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Susan E Graf owns 2 companies in total, including Epizyme Inc (EPZM) , and Finch Therapeutics Group Inc (FNCH) .

Click here to see the complete history of Susan E Graf’s form 4 insider trades.

Insider Ownership Summary of Susan E Graf

Ticker Comapny Transaction Date Type of Owner
EPZM Epizyme Inc 2016-04-25 Chief Business Officer
FNCH Finch Therapeutics Group Inc 2023-06-09 director

Susan E Graf Latest Holdings Summary

Susan E Graf currently owns a total of 1 stock. Susan E Graf owns 167 shares of Finch Therapeutics Group Inc (FNCH) as of June 9, 2023, with a value of $2,004.

Latest Holdings of Susan E Graf

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
FNCH Finch Therapeutics Group Inc 2023-06-09 167 12.00 2,004

Holding Weightings of Susan E Graf


Susan E Graf Form 4 Trading Tracker

According to the SEC Form 4 filings, Susan E Graf has made a total of 1 transactions in Finch Therapeutics Group Inc (FNCH) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Finch Therapeutics Group Inc is the acquisition of 167 shares on June 9, 2023, which cost Susan E Graf around $1,353.

Insider Trading History of Susan E Graf

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Susan E Graf Trading Performance

GuruFocus tracks the stock performance after each of Susan E Graf's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Susan E Graf is -23.86%. GuruFocus also compares Susan E Graf's trading performance to market benchmark return within the same time period. The performance of stocks bought by Susan E Graf within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Susan E Graf's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Susan E Graf

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 13.78 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 11.45 LIMIT LIMIT LIMIT LIMIT LIMIT

Susan E Graf Ownership Network

Ownership Network List of Susan E Graf

No Data

Ownership Network Relation of Susan E Graf

Insider Network Chart

Susan E Graf Owned Company Details

What does Epizyme Inc do?

Who are the key executives at Epizyme Inc?

Susan E Graf is the Chief Business Officer of Epizyme Inc. Other key executives at Epizyme Inc include Chief Scientific Officer Jeffery Kutok , Chief Operating Officer Jerald Korn , and Corporate Controller Joseph Beaulieu .

Epizyme Inc (EPZM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Epizyme Inc (EPZM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Epizyme Inc (EPZM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Epizyme Inc (EPZM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Epizyme Inc Insider Transactions

No Available Data

Susan E Graf Mailing Address

Above is the net worth, insider trading, and ownership report for Susan E Graf. You might contact Susan E Graf via mailing address: 400 Technology Square, 4th Floor, Cambridge Ma 02139.

Discussions on Susan E Graf

No discussions yet.